Edwards Lifesciences Profit Margin

Edwards Lifesciences's profit margin stands at 15.43% as of June 2026. That compares with 72.96% in the prior-year period — down 78.8% year over year. That is above the Healthcare sector average of 13.89%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Edwards Lifesciences reported 15.43% in profit margin versus 72.96% a year earlier — a 78.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Edwards Lifesciences sits higher the Healthcare benchmark (13.89%) with a profit margin of 15.43%. That is roughly 11.1% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 15.43% for Edwards Lifesciences means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Edwards Lifesciences's profit margin evolved across reporting periods, while the comparison chart places EW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.